Gene therapy for hemophilia represents a groundbreaking advancement in the treatment of this genetic bleeding disorder.Traditionally, managing hemophilia required frequent injections of clotting factor, but innovations like Hemgenix therapy, which received FDA approval in November 2022, promise to change that narrative.